DNAJC7 and amyotrophic lateral sclerosis: Taken together, although the number of cases is limited, the present paper suggests that biallelic loss-of-function variants in DNAJC7 cause a familial form of ALS whose clinical and pathological phenotype is indistinguishable from that of sporadic ALS, and emphasizes DNAJC7 as a promising therapeutic target for ALS.